Nanako Takaoka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nanako Takaoka has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Koya Obara
Department of Dermatology, Kitasato University School of Medicine, Sagamihara, Japan
1 shared publicationKyoumi Shirai
Department of Dermatology, Kitasato University School of Medicine, Sagamihara, Japan
1 shared publicationMichiko Yamane
Department of Dermatology, Kitasato University Grad Sch Med Sci, Sagamihara, Japan
1 shared publicationNobuko Arakawa
Department of Dermatology, Kitasato University School of Medicine, Sagamihara, Japan
1 shared publication- Robert M. Hoffman
AntiCancer Inc., 7917 Ostrow St., San Diego, CA 92111, USA
1 shared publication Ryoichi Aki
Department of Dermatology, Kitasato University School of Medicine, Sagamihara, Japan
1 shared publication
Latest Publications
- 10 May 2022
- Published by Springer Nature in Medical Molecular Morphology
- Vol. 55 (3) , 248-257
Hair-follicle-associated pluripotent (HAP) stem cells differentiate into mature beating cardiomyocyte sheets on flexible substrates in vitro
Cardiomyocytes have been differentiated from various stem cells such as human embryonic stem cells (ESC) and induced pluripotent stem cells (iPSC), but it is difficult to produce mature cardiomyocytes. We showed rat hair-follicle-associated pluripotent (HAP) stem cells have pluripotency and produced mature beating cardiomyocyte sheets differentiated from rat HAP stem cells. The upper parts of rat vibrissa hair follicles were cultured in 10% FBS DMEM and stained with antibodies of the ectoderm, mesoderm, endoderm system to show the differentiation of multiple cell types. Moreover, HAP stem cells were cultured under three different conditions to decide the most suitable culture conditions for making beating cardiomyocyte sheets. The beating cardiomyocyte sheets were shown to be mature by staining sarcomere structures. Isoproterenol alone and the combination of isoproterenol, activin A, bone morphogenetic protein 4 (BMP4) and basic fibroblast growth factor (bFGF) effectively induced beating long-fiber cardiomyocytes, which formed beating sheets, only in the presence of all four agents. Flexible substrates were essential for the differentiation of sheets of mature beating cardiomyocytes for HAP stem cells. The features of the cardiomyocytes differentiated from HAP stem cells demonstrate they have clinical potential for heart regeneration.
- 10 May 2022
- Published by Springer Nature in Medical Molecular Morphology
- Vol. 55 (3) , 248-257
Hair-follicle-associated pluripotent (HAP) stem cells differentiate into mature beating cardiomyocyte sheets on flexible substrates in vitro
Cardiomyocytes have been differentiated from various stem cells such as human embryonic stem cells (ESC) and induced pluripotent stem cells (iPSC), but it is difficult to produce mature cardiomyocytes. We showed rat hair-follicle-associated pluripotent (HAP) stem cells have pluripotency and produced mature beating cardiomyocyte sheets differentiated from rat HAP stem cells. The upper parts of rat vibrissa hair follicles were cultured in 10% FBS DMEM and stained with antibodies of the ectoderm, mesoderm, endoderm system to show the differentiation of multiple cell types. Moreover, HAP stem cells were cultured under three different conditions to decide the most suitable culture conditions for making beating cardiomyocyte sheets. The beating cardiomyocyte sheets were shown to be mature by staining sarcomere structures. Isoproterenol alone and the combination of isoproterenol, activin A, bone morphogenetic protein 4 (BMP4) and basic fibroblast growth factor (bFGF) effectively induced beating long-fiber cardiomyocytes, which formed beating sheets, only in the presence of all four agents. Flexible substrates were essential for the differentiation of sheets of mature beating cardiomyocytes for HAP stem cells. The features of the cardiomyocytes differentiated from HAP stem cells demonstrate they have clinical potential for heart regeneration.